Canagliflozin/metformin, sold under the brand name Vokanamet among others, is a fixed-dose combination anti-diabetic medication used for the treatment...
7 KB (438 words) - 05:00, 6 July 2024
disease. Canagliflozin decreases HbA1c levels by 0.77% to 1.16% when given by itself, in combination with metformin, in combination with metformin and a...
29 KB (2,960 words) - 20:56, 4 September 2024
Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of Type 2 diabetes, particularly in...
151 KB (14,475 words) - 01:04, 25 October 2024
Sitagliptin/metformin, sold under the brand name Janumet among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes...
11 KB (777 words) - 05:13, 27 October 2024
Dapagliflozin/metformin, sold under the brand name Xigduo Xr among others, is a fixed-dose combination anti-diabetic medication used as an adjunct to...
10 KB (472 words) - 03:59, 6 July 2024
Empagliflozin/metformin, sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes...
9 KB (556 words) - 05:32, 18 July 2024
Dapagliflozin (redirect from Dapagliflozin/metformin hydrochloride)
to recommend they be stopped temporarily before scheduled surgery. Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three...
53 KB (4,975 words) - 03:43, 30 September 2024
Pioglitazone/metformin, sold under the brand name Actoplus Met among others, is a fixed-dose combination anti-diabetic medication used to improve glycemic...
7 KB (536 words) - 05:58, 18 March 2024
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication...
5 KB (184 words) - 11:47, 3 November 2024
infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 diabetes. They...
4 KB (345 words) - 21:52, 3 April 2023
Vildagliptin (section Combination with metformin)
Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral treatment for type-2 diabetes...
8 KB (688 words) - 06:01, 17 June 2024
cannot be controlled by proper dietary management and exercise and when metformin has already been tried. National Kidney Foundation (2012 Update) claims...
18 KB (1,514 words) - 15:51, 7 June 2024
September 2015, the FDA issued a warning related to canagliflozin (Invokana) and canagliflozin/metformin (Invokamet) due to decreased bone mineral density...
44 KB (4,537 words) - 07:53, 5 November 2024
infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to dipeptidyl peptidase-4 inhibitors for the treatment of...
16 KB (1,798 words) - 07:40, 1 February 2024
in combination with other medicines for type 2 diabetes, in particular metformin, sulfonylureas, thiazolidinediones, and insulin taken concomitantly with...
16 KB (1,542 words) - 20:53, 21 September 2024
Alogliptin (redirect from Alogliptin/metformin)
commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone. In April 2016, the U.S. Food...
12 KB (894 words) - 22:13, 31 March 2024
potentially other antidiabetic medication. It is a treatment option after metformin and sulfonylureas. It is given by injection under the skin. Common side...
31 KB (2,842 words) - 16:57, 5 November 2024
type 2 diabetes as an adjunct to diet and exercise; as monotherapy when metformin is considered inappropriate due to intolerance; in addition to other medicinal...
41 KB (3,676 words) - 19:19, 4 October 2024
combination therapy of repaglinide together with the generic anti-diabetic drug metformin. This new patent was due to expire June 2018. In January 2011, a federal...
10 KB (990 words) - 13:31, 19 December 2023
"Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes". ClinicalTrials.gov. October 2019. Archived...
72 KB (6,068 words) - 21:55, 6 November 2024
approved in 2019, consisting of metformin, saxagliptin, and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin...
51 KB (5,305 words) - 19:29, 4 November 2024
older with type 2 diabetes mellitus: to improve glycemic control when metformin and/or sulphonylurea (SU) and empagliflozin or linagliptin do not provide...
9 KB (467 words) - 06:10, 16 July 2024
conjunction with exercise and diet. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is taken by mouth. Common...
11 KB (607 words) - 05:27, 10 June 2024
a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life...
32 KB (2,752 words) - 00:10, 2 November 2024
Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
44 KB (3,512 words) - 16:20, 8 November 2024
Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
4 KB (328 words) - 05:24, 6 August 2024
anti-diabetic medication used to treat type 2 diabetes. It may be used with metformin, a sulfonylurea, or insulin. Use is recommended together with exercise...
28 KB (2,663 words) - 03:58, 30 September 2024
Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type...
6 KB (402 words) - 13:08, 16 July 2024
Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
9 KB (746 words) - 07:01, 29 May 2024
Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
24 KB (1,877 words) - 07:44, 5 October 2024